Institutional Ownership
Aslan Pharmaceuticals Lt Adr
CUSIP 04522R309COMASLNEURQ1 2026
Insider transactions
We couldn't map Aslan Pharmaceuticals Lt Adr to an SEC issuer (CIK) yet, so Form 4 insider data isn't available. This resolves automatically as ticker enrichment expands.